InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: georgejjl post# 348004

Tuesday, 02/01/2022 1:53:18 PM

Tuesday, February 01, 2022 1:53:18 PM

Post# of 462630
Another Blarcamesine Success, in Humans

Anavex/blarcamesine naysayers really have to stretch to find facts that show that the drug is either unsafe or ineffective. Have we seen any of those failures laid out today? The clinical outcomes from the completed clinical trial in humans, with advanced cases of Rett syndrome, are all positive. Not a single datum (compared to placebo) was negative. All clinical outcomes are statistically significant.

https://www.anavex.com/_files/ugd/79bcf7_ca78f07355544ad794235b95a121f8d0.pdf

This continues the universally positive findings in every clinical study of blarcamesine; first in trans-genic (human-diseased) murines (lab rodents), now in a placebo-controlled Phase 3 clinical study in diseased humans. This will continue with the Parkinson's disease dementia and Alzheimer's trials. For blarcamesine, the FDA will have it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News